A regional hospital in Western Australia notified prescribers this week that piperacillin/tazobactam is down to one week’s supply. The contracted delivery was pushed out five weeks. The backup wholesaler is expected to have the same problem. Pip/taz is now effectively rationed.
This matters clinically in a way the phrase “medicine shortage” doesn’t capture. Piperacillin/tazobactam is a broad-spectrum IV antibiotic — a first-line empirical treatment for intra-abdominal sepsis, hospital-acquired pneumonia, and neutropenic fever. When you substitute away from it, you are not swapping one brand of paracetamol for another. You are making a harder clinical bet with a narrower drug in a patient who is already critically unwell. The pharmacy rationing decision has already moved clinical risk onto patients. The risk doesn’t appear in any procurement spreadsheet.
Antibiotic shortages have quietly become routine. Between 2022 and 2023, 86% of oral antibiotics available in Australia had at least one reported shortage. For ten active ingredients, shortages ran longer than 300 days. The TGA has been issuing emergency substitution instruments and approving overseas-registered alternatives continuously since 2022. The list has not shortened.
A vial of piperacillin/tazobactam costs a few dollars. It is taken for days, not months. The patent in Australia expired decades ago. There is no commercial incentive to maintain redundant production capacity for a drug like that, so manufacturers don’t. Production has consolidated into a small number of overseas facilities supplying the entire global market. Hospital procurement contracts typically reward the cheapest compliant supplier and are often silent with regard to buffer stock. Hospitals hold minimal inventory because drugs expire and warehouse space costs money.
What is absent from this picture is any policy obligation to hold strategic reserves — at the wholesaler level, at the hospital level, or anywhere in between. The patient arriving in sepsis next week has no idea that the drug most likely to help them may not be there. They don’t need to understand procurement philosophy to bear the consequence of it. Resilience was never part of the contract.
Editor’s note: Australia does not meet its IEA obligation to hold 90 days of liquid fuel reserves. It currently holds fewer than 30. The same logic that produces that failure produces this one.